Jiangxi Synergy Pharmaceutical Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Zhengwei Pang
Chief executive officer
CN¥916.8k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 19.8yrs |
| CEO ownership | n/a |
| Management average tenure | 13.9yrs |
| Board average tenure | 7.1yrs |
Recent management updates
Recent updates
Jiangxi Synergy Pharmaceutical Co., Ltd. (SZSE:300636) Stock Rockets 43% But Many Are Still Ignoring The Company
Oct 08
Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?
Jun 28Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues
May 01Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up
Apr 27CEO
Zhengwei Pang (62 yo)
19.8yrs
Tenure
CN¥916,800
Compensation
Mr. Zhengwei Pang has been the Chairman and General Manager of Jiangxi Synergy Pharmaceutical Co., Ltd. since April 2005.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 19.8yrs | CN¥916.80k | no data | |
| Vice Chairman & Deputy GM | 9.9yrs | CN¥667.80k | no data | |
| Financial Director | 9.9yrs | CN¥369.00k | 0.031% CN¥ 1.0m | |
| Deputy GM & Director | 14yrs | CN¥672.60k | 1.26% CN¥ 41.1m | |
| Deputy GM & Director | 9.8yrs | CN¥674.20k | 0.38% CN¥ 12.4m | |
| Deputy GM & Secretary of the Board | 10.8yrs | CN¥614.40k | 0.18% CN¥ 5.8m | |
| Supervisor & Chief Dispatcher of Production Technology Department | 21yrs | no data | no data |
13.9yrs
Average Tenure
59yo
Average Age
Experienced Management: 300636's management team is seasoned and experienced (13.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 19.8yrs | CN¥916.80k | no data | |
| Vice Chairman & Deputy GM | 9.9yrs | CN¥667.80k | no data | |
| Deputy GM & Director | 14yrs | CN¥672.60k | 1.26% CN¥ 41.1m | |
| Deputy GM & Director | 9.8yrs | CN¥674.20k | 0.38% CN¥ 12.4m | |
| Supervisor & Chief Dispatcher of Production Technology Department | 9.9yrs | no data | no data | |
| Independent Director | 2.7yrs | CN¥60.00k | no data | |
| Supervisory Board Chairman | 6.7yrs | no data | 0.13% CN¥ 4.1m | |
| Independent Director | 3.8yrs | CN¥60.00k | no data | |
| Non-Independent Director | 6.7yrs | CN¥401.40k | 0.025% CN¥ 807.7k | |
| Non-Independent Director | 7.5yrs | CN¥434.10k | 0.054% CN¥ 1.8m | |
| Independent Director | 3.8yrs | CN¥60.00k | no data | |
| Employee Representative Supervisor | 3.8yrs | no data | no data |
7.1yrs
Average Tenure
59.5yo
Average Age
Experienced Board: 300636's board of directors are considered experienced (7.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 18:30 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangxi Synergy Pharmaceutical Co., Ltd. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kai Wang | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Jiaxi Xu | Industrial Securities Co. Ltd. |